Mikael Dolsten - Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mikael Dolsten since 04 Mar 2025

Holdings reported by Mikael Dolsten for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 24,135 $505,869 $20.96 27 Feb 2026 Direct Common Stock
Common Stock 14,312 $315,579 $22.05 27 Feb 2026 Direct

Transactions reported by Mikael Dolsten for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.